You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

ETHINYL ESTRADIOL - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for ethinyl estradiol and what is the scope of freedom to operate?

Ethinyl estradiol is the generic ingredient in two hundred and thirty-three branded drugs marketed by Schering, Pharmacia And Upjohn, Organon Usa Inc, Gd Searle Llc, Watson Pharms Teva, Watson Labs, Xiromed, Barr, Novast Labs, Dr Reddys Labs Sa, Amneal, Teva Pharms Usa Inc, Organon Usa Organon, Pfizer, Parke Davis, Agile, Glenmark Pharms Ltd, Avion Pharms, Lupin Ltd, Aurobindo Pharma Ltd, Amneal Pharms, Aurobindo Pharma, Teva Branded Pharm, Wyeth Pharms Inc, Sun Pharm, Exeltis Usa Inc, Cadence Health, Duramed Pharms Barr, Bayer Hlthcare, Wyeth Pharms, Novast Labs Ltd, Hetero Labs, Naari Pte Ltd, Endo Operations, Zydus Noveltech Inc, Teva Pharms Usa, Janssen Pharms, Mylan Technologies, Apil, Allergan, Ortho Mcneil Pharm, LPI, Watson Labs Teva, Ortho Mcneil Janssen, Warner Chilcott, Mylan Labs Ltd, Warner Chilcott Llc, Wilshire Pharms Inc, Millicent Pr, Lupin, Barr Labs Inc, Apotex, Glenmark Speclt, Lupin Pharms, Mylan, and Mayne Pharma, and is included in three hundred and two NDAs. There are seventeen patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are sixteen drug master file entries for ethinyl estradiol. There are three tentative approvals for this compound.

Drug Prices for ETHINYL ESTRADIOL

See drug prices for ETHINYL ESTRADIOL

Recent Clinical Trials for ETHINYL ESTRADIOL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
McGill University Health Centre/Research Institute of the McGill University Health CentrePhase 4
Alexion Pharmaceuticals, Inc.Phase 1
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)N/A

See all ETHINYL ESTRADIOL clinical trials

Generic filers with tentative approvals for ETHINYL ESTRADIOL
Applicant Application No. Strength Dosage Form
⤷  Sign Up⤷  Sign Up0.03MG,0.01MG; 0.15MG,N/ATABLET;ORAL
⤷  Sign Up⤷  Sign Up0.02MG,0.15MG;0.025MG,0.15MG;0.03MG,0.15MG;0.01MG,N/ATABLET;ORAL
⤷  Sign Up⤷  Sign Up0.01MG,0.01MG;1MG,N/ATABLET;ORAL

The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.

Medical Subject Heading (MeSH) Categories for ETHINYL ESTRADIOL

US Patents and Regulatory Information for ETHINYL ESTRADIOL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amneal Pharms NORGESTIMATE AND ETHINYL ESTRADIOL ethinyl estradiol; norgestimate TABLET;ORAL-28 203865-001 Oct 27, 2015 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Duramed Pharms Barr AVIANE-28 ethinyl estradiol; levonorgestrel TABLET;ORAL-28 075796-001 Apr 30, 2001 AB1 RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Naari Pte Ltd NORGESTIMATE AND ETHINYL ESTRADIOL ethinyl estradiol; norgestimate TABLET;ORAL-28 200384-001 Apr 7, 2015 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Xiromed NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE ethinyl estradiol; norethindrone acetate TABLET;ORAL 202742-001 Oct 30, 2014 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.